INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (102155, 213, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159682, 1768159682, NULL, NULL, NULL, NULL, NULL, NULL, NULL);